BDBM50334035 2-methyl-4-(2-(4-(3-(trifluoromethyl)phenyl)-1H-imidazol-2-yl)benzyl)morpholine::CHEMBL1644738

SMILES CC1CN(Cc2ccccc2-c2nc(c[nH]2)-c2cccc(c2)C(F)(F)F)CCO1

InChI Key InChIKey=OHDGLYGQXSEPBY-UHFFFAOYSA-N

Data  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50334035   

TargetCannabinoid receptor 2(Human)
Merck Research Laboratory

Curated by ChEMBL
LigandPNGBDBM50334035(2-methyl-4-(2-(4-(3-(trifluoromethyl)phenyl)-1H-im...)
Affinity DataEC50:  510nMAssay Description:Agonist activity at human cloned CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2011
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Merck Research Laboratory

Curated by ChEMBL
LigandPNGBDBM50334035(2-methyl-4-(2-(4-(3-(trifluoromethyl)phenyl)-1H-im...)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at human cloned CB1 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2011
Entry Details Article
PubMed